Filing Flows › Autolus Therapeutics (AUTL) › Product revenue, net revenue
Autolus Therapeutics (AUTL) Product revenue, net revenue by quarter
Autolus Therapeutics' Product revenue, net revenue was $45.7M in Q2 2026 (second quarter 2026), +96% from Q4 2025. Over the last 3 quarters it ranged from $21.1M (Q3 2025) to $45.7M (Q2 2026).
| Quarter | Product revenue, net revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $45.7M | +96% | — |
| Q4 2025 | $23.3M | +10% | — |
| Q3 2025 | $21.1M | — | — |
Q2 2026 at a glance
Autolus Therapeutics, Q2 2026: revenue $45.7M (+118% year over year), operating margin -95.9%, net loss $39.1M, operating cash flow −$25.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Autolus Therapeutics' Product revenue, net revenue?
Autolus Therapeutics' Product revenue, net revenue was $45.7M in Q2 2026 (second quarter 2026), +96% from Q4 2025.
How has Autolus Therapeutics' Product revenue, net revenue changed?
Over the last 3 quarters it ranged from $21.1M (Q3 2025) to $45.7M (Q2 2026).